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Abstract
Herpes simplex virus (HSV) uses intranuclear compartmentalization to concentrate the viral and cellular factors required for the
progression of the viral life cycle. Processes as varied as viral DNA replication, late gene expression, and capsid assembly take place within
discrete structures within the nucleus called replication compartments. Replication compartments are hypothesized to mature from a few
distinct structures, called prereplicative sites, that form adjacent to cellular nuclear matrix-associated ND10 sites. During productive
infection, the HSV single-stranded DNA-binding protein ICP8 localizes to replication compartments. To further the understanding of
replication compartment maturation, we have constructed and characterized a recombinant HSV-1 strain that expresses an ICP8 molecule
with green fluorescent protein (GFP) fused to its C terminus. In transfected Vero cells that were infected with HSV, the ICP8–GFP protein
localized to prereplicative sites in the presence of the viral DNA synthesis inhibitor phosphonoacetic acid (PAA) or to replication
compartments in the absence of PAA. A recombinant HSV-1 strain expressing the ICP8–GFP virus replicated in Vero cells, but the yield
was increased by 150-fold in an ICP8-complementing cell line. Using the ICP8–GFP protein as a marker for replication compartments, we
show here that these structures start as punctate structures early in infection and grow into large, globular structures that eventually fill the
nucleus. Large replication compartments were formed by small structures that either moved through the nucleus to merge with adjacent
compartments or remained relatively stationary within the nucleus and grew by accretion and fused with neighboring structures.
© 2003 Elsevier Science (USA). All rights reserved.
Introduction
Herpes simplex virus (HSV) is a large double-stranded
DNA virus that replicates within the nucleus of the infected
cell. As such, many viral processes must occur within the
nucleus during the course of infection including viral tran-
scription (Knipe et al., 1987; Leopardi et al., 1997; Phelan
et al., 1997; Randall and Dinwoodie, 1986; Rice et al.,
1994), viral DNA synthesis (de Bruyn Kops and Knipe,
1988; Phelan et al., 1997; Randall and Dinwoodie, 1986),
and virion assembly and DNA packaging (de Bruyn Kops et
al., 1998; Lamberti and Weller, 1998; Ward et al., 1996; Yu
and Weller, 1998). While these processes are temporally
regulated by the viral cascade of immediate-early, early, and
late gene expression (Roizman and Knipe, 2001), there is an
additional level of spatial control imposed within the nu-
cleus. Viral processes do not take place diffusely within the
nucleus, but within globular intranuclear structures called
replication compartments (Bush et al., 1991; de Bruyn Kops
and Knipe, 1988; de Bruyn Kops et al., 1998; Knipe et al.,
1987; Phelan et al., 1997; Quinlan et al., 1984).
HSV employs the strategy of intranuclear compartmen-
talization to organize the processes required for viral repli-
cation, which allows for the local accumulation of diffuse or
limiting factors, be they individual proteins, large protein
complexes, or small biological molecules, to promote a
biological process. The mammalian cell uses compartmen-
talization to organize intranuclear operations, with subcom-
partments associated with various cellular processes. The
majority of the nucleus is composed of the chromatin com-
partment, which is subdivided into transcriptionally active
euchromatin or transcriptionally silent heterochromatin. In-
dividual chromosomes occupy defined regions within the
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nucleus called “chromosome territories,” with euchromatin
more centrally located within the nucleus and the hetero-
chromatin located near the nuclear periphery (Abney et al.,
1997; Carmo-Fonseca, 2002; Chubb et al., 2002; Ferreira et
al., 1997; Manders et al., 1999; Qumsiyeh, 1999; Sadoni et
al., 1999; Zink et al., 1998).
Running throughout the interchromosomal spaces are
channels or streams of nucleoplasm in which processes
involved in RNA metabolism and trafficking are found
(Politz and Pederson, 2000). Other nuclear compartments
within the interchromosomal spaces include the nucleolus,
which is the major site of ribosome biogenesis (Carmo-
Fonseca et al., 2000), the nuclear speckles that house spli-
ceosomal components (Misteli et al., 1997), the Cajal bod-
ies (formerly known as coiled bodies) that are involved in
the generation of snRNPs (Gall, 2000), and the ND10 sites,
which may serve as depots for transcriptional regulators
(Ascoli and Maul, 1991; Everett et al., 1999; Hodges et al.,
1998; Maul et al., 2000; Zhong et al., 2000). Many of these
structures, such as chromatin and the ND10 sites, are an-
chored within the nucleus by direct association with the
nuclear matrix (Ascoli and Maul, 1991; Chubb et al., 2002;
Hodges et al., 1998), while others are associated with spe-
cific genomic loci, as is the case with Cajal bodies and
histone gene clusters (Gall, 2000). Within this well-orga-
nized intranuclear environment, the virus must initiate its
life cycle by accumulating the required cellular and viral
factors and the incoming parental genome at the same site
within the host nucleus. The assembling of these sites is
influenced and possibly limited by the preexisting nuclear
architecture (de Bruyn Kops and Knipe, 1994). For exam-
ple, in binucleate CV-1 cells infected with HSV, similar
patterns of replication compartments, some even mirror
images, were observed in the adjacent sister nuclei (de
Bruyn Kops and Knipe, 1994).
Replication compartments were initially defined by the
presence of the HSV single-stranded DNA-binding protein,
ICP8 (Quinlan et al., 1984). Other viral proteins known to
accumulate within replication compartments include the or-
igin-binding protein (UL9), the heterotrimeric helicase–pri-
mase complex (UL5/UL8/UL52), polymerase and its acces-
sory factor (UL30/UL42), the immediate-early ICP27
protein, the ICP4 viral transactivator protein, and the ICP5
capsid protein (Bush et al., 1991; de Bruyn Kops et al.,
1998; Knipe et al., 1987; Liptak et al., 1996; Lukonis and
Weller, 1996; Phelan et al., 1997). Cellular proteins that are
involved in DNA replication, such as PCNA, DNA ligase,
and RP-A, are also recruited to replication compartments
(de Bruyn Kops and Knipe, 1988; Wilcock and Lane, 1991),
but their participation in viral replication has not been de-
termined. The above-mentioned viral proteins are contained
within subcompartments within replication compartments,
with some proteins, such as ICP8, distributed to punctate
foci within compartments, and others, such as ICP4, distrib-
uted diffusely within compartments (de Bruyn Kops et al.,
1998). Viral DNA synthesis, as detected by BrdU incorpo-
ration (de Bruyn Kops and Knipe, 1988), and viral tran-
scription, as detected by RNA pulse-labeling and by the
presence of the cellular RNA polymerase II (Leopardi et al.,
1997; Phelan et al., 1997; Rice et al., 1994), both occur
within replication compartments.
In the absence of viral replication, as with the treatment
with the viral DNA synthesis inhibitor phosphonoacetic
acid (PAA), the viral replication proteins including ICP8,
the origin-binding protein, and the helicase–primase com-
plex are distributed within the nucleus to punctate structures
called prereplicative sites (de Bruyn Kops and Knipe, 1988;
Liptak et al., 1996; Lukonis and Weller, 1996; Quinlan et
al., 1984). Because the replication proteins associate with
these structures in the absence of viral DNA synthesis, they
are hypothesized to be an early stage of protein accumula-
tion and, thus, the precursors to replication compartments.
However, in the presence of PAA, two populations of pre-
replicative sites are observed (Lukonis et al., 1997; Upri-
chard and Knipe, 1997). One population, the S-phase-de-
pendent prereplicative sites, co-localize with sites of
cellular DNA synthesis, as shown by BrdU incorporation
(Uprichard and Knipe, 1997). In contrast, the other popula-
tion, the S-phase-independent prereplicative sites, form ad-
jacent to cellular ND10 sites (Uprichard and Knipe, 1997).
The function of ND10 sites is unknown, but it has been
suggested that they are involved in processes as varied as
transcriptional control, cell growth and regulation, and an-
tiviral defense (Ascoli and Maul, 1991; Maul et al., 2000;
Negorev and Maul, 2001; Zhong et al., 2000). The “nuclear
domain 10” or ND10 structures vary in number in mamma-
lian cells in the range of 10–30 per nucleus, and are gen-
erally 0.2–1.0 m in diameter (Everett et al., 1999; Hodges
et al., 1998; Zhong et al., 2000). The size and number of
ND10 structures change during the cell cycle, which varies
with the presence of hormones or interferon, possibly via a
pathway regulated by the promyelocytic leukemia protein
(PML) (Everett et al., 1999; Hodges et al., 1998; Negorev
and Maul, 2001; Zhong et al., 2000). While ND10 structures
have been found in numerous cell types in cultured cells or
in vivo, they have yet to be detected in cells of a neuronal
lineage (Negorev and Maul, 2001). The role that ND10
structures play in viral infection is also unclear as these
structures are disrupted soon after infection by the viral
immediate-early gene product ICP0, possibly via a protea-
some-dependent mechanism (Everett et al., 1998; Everett
and Maul, 1994). It has previously been shown that incom-
ing genomes of various viruses including HSV, SV40, and
adenovirus are deposited near ND10 structures in the ab-
sence of viral protein production via an unknown mecha-
nism (Ishov and Maul, 1996; Maul et al., 1996). However,
the cellular machinery that one might imagine that a virus
would require to replicate its genome is not present at these
sites and must be recruited to the parental genome(s). In
contrast, the S-phase-dependent sites are regions of active
cellular DNA synthesis and presumably contain the cellular
machinery needed for viral DNA synthesis (de Bruyn Kops
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and Knipe, 1988; Uprichard and Knipe, 1997). It is possible
that the virus may usurp these preformed replication com-
plexes for its own purposes and that these sites are the
precursors of viral replication compartments.
ICP8 is a 125-kDa multifunctional zinc metalloprotein
encoded by the UL29 gene (Gao et al., 1988; Gupte et al.,
1991; Quinn and McGeoch, 1985) and is expressed with
early kinetics (Honess and Roizman, 1974). ICP8 exhibits a
preference for binding single-stranded DNA, but can bind
double-stranded DNA (Lee and Knipe, 1985; Ruyechan,
1983; Ruyechan and Weir, 1984). ICP8 binds nonspecifi-
cally to DNA in a cooperative manner (Lee and Knipe,
1985). ICP8 also has the ability to destabilize double-
stranded DNA (Boehmer and Lehman, 1993a) and can pro-
mote DNA strand transfer (Bortner et al., 1993) and rena-
turation of complementary DNA strands (Dutch and
Lehman, 1993), which suggests that ICP8 may play a role in
HSV genome recombination. In addition to its role in viral
DNA synthesis, ICP8 has also been shown to regulate viral
gene expression by repressing transcription from the paren-
tal genome (Godowski and Knipe, 1983; Godowski and
Knipe, 1985; Godowski and Knipe, 1986) and stimulating
late gene expression from progeny genomes (Chen and
Knipe, 1996; Gao and Knipe, 1991).
The requirements for the targeting of ICP8 within the
nucleus may depend on the conditions examined. In trans-
fected cells, the co-expression of the three components of
the helicase–primase complex (UL5, UL8, and UL52) is
sufficient to localize ICP8 to punctate prereplicative sites
(Liptak et al., 1996; Lukonis and Weller, 1996). In infected
cells, the requirements for ICP8 intranuclear localization
may be different because, in addition to the helicase–pri-
mase complex, the origin-binding protein (UL9) is also
required (Liptak et al., 1996; Lukonis and Weller, 1996).
ICP8 has been shown to interact either physically or
functionally with several of the other viral replication pro-
teins including the origin-binding protein (Boehmer, 1998;
Boehmer and Lehman, 1993b; He, 2001; Lee and Lehman,
1997; Makhov et al., 1996), the helicase–primase complex
(Falkenberg, Elias, and Lehman, 1998; Hamatake et al.,
1997; Le Gac, 1996), and polymerase (Chiou et al., 1985;
Hernandez and Lehman, 1990; O’Donnell et al., 1987;
Ruyechan and Weir, 1984). As ICP8 is required for prerep-
licative site and replication compartment formation (de
Bruyn Kops and Knipe, 1988; Liptak, Uprichard, and
Knipe, 1996; Quinlan, Chen, and Knipe, 1984), and because
its intranuclear distribution is well characterized, we chose
ICP8 as a marker for viral replication structures and to focus
on the intranuclear movement of ICP8 as a model system to
study replication compartment formation in infected cells.
To achieve this, we fused the coding sequence from green
fluorescent protein (GFP) to the C-terminal ICP8 sequence
to analyze the formation of prereplicative sites and replica-
tion compartments in living cells.
Results
The number of viral functions occurring within replica-
tion compartments speaks to the significance of these struc-
tures in the viral replication cycle, but little is known about
how these structures form and mature to occupy almost the
entire volume of the nucleus (Monier et al., 2000). We
initiated these studies to determine if replication compart-
ments originated from a few distinct structures in the nu-
cleus or if they formed from the coalescence of numerous
sites within the nucleus. It is likely that the few S-phase-
independent prereplicative sites observed adjacent to cellu-
lar ND10 sites (Uprichard and Knipe, 1997) and not the
numerous S-phase-dependent prereplicative sites are the
precursors to the large replication compartments observed
later during infection (de Bruyn Kops and Knipe, 1988),
based on the evidence that the incoming viral genome and
viral proteins accumulate at sites adjacent to ND10 sites
(Ishov and Maul, 1996; Maul et al., 1996; Uprichard and
Knipe, 1997). However, it was unclear how these few small
sites eventually form the large replication compartments
observed later in infection. To analyze this, we constructed
a recombinant HSV-1 strain expressing an ICP8–GFP fu-
sion protein to examine prereplicative site and replication
compartment formation in cultured cells.
Construction of an ICP8–GFP fusion gene
We first constructed vectors that expressed an ICP8 mol-
ecule with GFP fused to the C- or N-terminus. The C-
terminal ICP8–GFP fusion protein consists of the entire
1196 amino acid residues of ICP8, an 18-amino-acid residue
linker region, and the 239 amino acid residues of GFP. The
predicted size of the C-terminal ICP8–GFP fusion protein
was 157 kDa. The N-terminal GFP–ICP8 protein consisted
of the 239 residues of GFP fused to the 1196 residues of
ICP8 with 3 residues as a linker region. We constructed
plasmids that expressed a C-terminal ICP8–GFP fusion
protein under the control of the CMV promoter pCMV-
8GFP (Fig. 1A), and an N-terminal ICP8–GFP fusion pro-
tein under the control of the CMV promoter pCMV-GFP8
(Fig. 1A) or the ICP8 promoter p8-8GFP (Fig. 1B).
Localization of the ICP8–GFP protein in transfected cells
When expressed in the absence of other viral proteins in
transfected Vero cells, the ICP8–GFP fusion protein
showed a diffuse distribution within the nucleus (Fig. 2A).
The ICP8–GFP fusion protein localized to viral replication
compartments after infection with the replication-defective
HD-2 ICP8 mutant virus (Fig. 2C), which expresses the
N-terminal 250 amino acid residues of ICP8 fused in-frame
to lacZ. When the specific viral DNA synthesis inhibitor
PAA was present during HD-2 infection, the ICP8–GFP
fusion protein localized to punctate prereplicative sites (Fig.
2E). Similar results were observed with wild-type KOS 1.1
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infection of transfected Vero cells (data not shown). The
addition of GFP to the C terminus of ICP8 did not alter its
localization to prereplicative sites or replication compart-
ments in transfected Vero cells infected with HSV. There-
fore, the ICP8–GFP fusion protein behaved as described
previously for wild-type ICP8 under similar conditions. The
addition of GFP to the N terminus of ICP8 resulted in a
protein that did not localize to replication compartments
(data not shown). The N-terminal ICP8–GFP fusion protein
had a tendency to aggregate nonspecifically in the nuclei of
transfected cells (data not shown). For these reasons, we
used only the C-terminal ICP8–GFP fusion protein for our
experiments.
Complementation of the HD-2 mutant virus
We next tested the ability of the C-terminal ICP8–GFP
fusion protein to complement the HD-2 ICP8 mutant virus,
which expresses the first 250 amino acid residues of ICP8
fused to lacZ. Vero cells transfected with the empty pCI
vector plasmid or plasmids expressing either wild-type
ICP8 or the ICP8–GFP fusion proteins were infected with
HD-2 virus. At 24 h postinfection, progeny virus was har-
vested, and the viral yield was determined on an ICP8-
complementing cell line. The ICP8–GFP fusion protein
could complement the growth of HD-2 in Vero cells by
50-fold over the negative control, but this was 40-fold less
than the level observed with the wild-type ICP8 protein
(Table 1). These results suggested that the addition of GFP
to the C terminus of ICP8 altered one or more functions of
ICP8 or that the ICP8–GFP fusion protein was not ex-
pressed to the levels required for efficient complementation
of the HD-2 virus. The N-terminal fusion protein failed to
complement an ICP8 mutant virus (Taylor, 2002).
Construction of an ICP8–GFP recombinant virus
We constructed a recombinant HSV strain expressing the
ICP8–GFP fusion protein via homologous recombination.
Purified HD-2 viral DNA and linearized pICP8–GFP plas-
mid DNA were co-transfected into the V827-complement-
ing cell line. At 4 days posttransfection, the progeny virus
was harvested and plated onto V827 cells. Fluorescent
plaques were identified and triply purified on V827 cells.
Stocks were grown on ICP8-complementing cell lines.
Fig. 2. Localization of the C-terminal ICP8–GFP fusion protein in trans-
fected cells. Vero cells were transfected with the p8-8GFP plasmid and
subsequently mock-infected or infected with the HD-2 ICP8 mutant virus.
Images were obtained at 6 h postinfection. (A) Mock-infected; (B) phase of
(A); (C) HD-2 infected; (D) phase of (C); (E) HD-2-infected in the
presence of PAA; (f) phase of (E).
Fig. 1. Diagram of the plasmids used in this study. (A) pCMV–8GFP and
pCMV-G8 plasmids, which express the C- (ICP8–GFP) and N-terminal
(GFP–ICP8) fusion proteins, respectively. (B) Top: HSV-1 genome, with
the location of the UL29 (ICP8) gene indicated. Bottom: p8-8GFP plasmid
that was used to generate the recombinant ICP8-GFP virus.
Table 1
Complementation of the HD-2 ICP8 mutant virus with ICP8–GFP
fusion protein
DNA transfecteda Yield (PFU/ml)b
pCI plasmid vector 1.4  102, 1.4  102
pCMV–ICP8 3.1  105, 5.6  105
pCMV–ICP8–GFP 8.0  103, 5.6  103
a Three micrograms of DNA was transfected and, at 24 h posttransfec-
tion, the cells were infected with HD-2 virus.
b Yield from duplicate samples determined on an ICP8-complementing
cell line.
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Detection of the ICP8–GFP fusion protein in infected
cells
The ICP8–GFP fusion protein was detected in [35S]me-
thionine- and cysteine-labeled infected Vero cells at 3.5,
6.5, and 9.5 h postinfection (Fig. 3A, lanes 3, 5, and 7).
While the ICP8–GFP was expressed with kinetics similar to
those of wild-type ICP8, it was expressed to lower levels.
This may have been the result of lower levels of synthesis or
due to a less stable protein as a result of the addition of GFP.
When the fusion protein was detected by Western blot of
infected Vero cell lysates with the 3–83 anti-ICP8 poly-
clonal antibody, it migrated near the approximate predicted
molecular size of 157 kDa (Fig. 3B, lane 2). The levels of
ICP8–GFP expressed in ICP8-complementing cells were
similar to those observed in Vero cells, suggesting that the
presence of wild-type ICP8 does not stabilize or otherwise
increase the expression of the ICP8–GFP fusion protein
(data not shown).
Growth properties of the ICP8–GFP recombinant virus
To determine if there was a growth defect associated
with the addition of GFP to the C terminus of ICP8, we
examined the kinetics of ICP8–GFP viral growth in both
ICP8-complementing V529 cells and noncomplementing
Vero cells (Fig. 4). Monolayers of cells infected at a m.o.i.
of 3 were harvested at various times postinfection. The viral
yield was determined on the ICP8-complementing cell line
V529, and the ICP8–GFP recombinant virus replicated on
Vero cells, but the yield was increased by 150-fold on the
V529-complementing cell line (Fig. 4). The growth differ-
ence of the ICP8–GFP recombinant virus may be due to the
lower levels of ICP8–GFP produced during infection com-
pared with wild-type ICP8 (Fig. 3A). It was possible that the
majority of Vero cells infected with the ICP8–GFP recom-
binant virus did not produce progeny virus and that only a
small percentage of infected cells produced progeny, thus
giving rise to a much lower yield. If only a few Vero cells
were producing the bulk of the progeny virus, it would be
expected that only those few Vero cells would contain
replication compartments. However, the number of Vero
cells containing replication compartments was not dramat-
Fig. 3. Analysis of protein expression in Vero cells. (A) At the indicated
times postinfection, Vero cells were labeled for 30 min with [35S]methi-
onine and harvested, and the proteins were separated by SDS–PAGE on a
9.25% gel. Vero cells were mock-infected (lane 1) or infected with wild-
type KOS 1.1 (lanes 2, 4, 6) or the ICP8–GFP virus (3, 5, 7). The positions
of several viral proteins are shown at the right. (B) Western blot analysis
of lysates from Vero cells infected either with wild-type KOS1.1 (lane 1)
or the ICP8–GFP (lane 2) virus.
Fig. 4. Viral growth curve. Vero or V529 cells were infected with either wild-type (wt) or ICP8–GFP (8GFP) virus. At 2, 12, and 24 h postinfection, the
cells were harvested, and the yields of duplicate samples were determined by titration on V529 cells.
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ically different from the number of V529 cells containing
replication compartments (Table 2), but the replication
compartments were smaller and in greater number in Vero
cells. Taken together, these results suggested that the ma-
jority of Vero cells are replicating viral DNA and producing
progeny virions, but possibly to a lower extent than in the
complementing cell line. Large stocks of the ICP8–GFP
recombinant virus at titers greater than 108 PFU/ml were
grown on an ICP8-complementing cell lines. Thus the ad-
dition of GFP to the C terminus of ICP8 did affect some
function(s) required for viral replication. The presence of
GFP at the C terminus may be acting in a steric manner by
partially blocking an interaction required for viral replica-
tion. However, the phenotype defect of ICP8–GFP could be
complemented by wild-type ICP8.
Viral DNA synthesis by the ICP8–GFP virus
ICP8 is required for viral DNA synthesis, so the growth
defect observed in Vero cells may be due in part to de-
creased levels of DNA synthesis in Vero cells. We infected
Vero cells with either wild-type virus or the ICP8–GFP
recombinant virus in the presence and absence of the spe-
cific viral DNA synthesis inhibitor PAA. At 16 h postinfec-
tion, the cells were harvested, and the total cellular DNA
was isolated. We blotted the DNA in fivefold dilutions to a
membrane and probed with an HSV-specific 32P-labeled
plasmid to quantify the relative amounts of viral DNA by
PhosphoImager analysis. The values were corrected for the
amount of input viral DNA, as measured by the signal from
the PAA-infection samples. The amount of viral DNA at
16 h postinfection in Vero cells infected with the ICP8–
GFP virus was 3% of the level of DNA synthesized in
wild-type virus-infected Vero cells (Fig. 5), as measured by
PhosphoImager analysis. Thus, a defect in viral DNA syn-
thesis was at least partially responsible for the growth dif-
ferences observed in Vero and ICP8-complementing cells.
UL9 binding assay
To determine if the decrease in viral replication was due
to the GFP moiety blocking an important protein interaction
with ICP8, we tested the ability of the ICP8–GFP fusion
protein to bind to a Staphylococcus aureus protein A–UL9
fusion protein that had previously been used to map the UL9
sites required for ICP8 binding (Arbuckle and Stow, 1993;
Boehmer et al., 1994). As a negative control, we used a
mutant protein A–UL9 fusion protein, D27, which was in-
capable of binding to ICP8 (Boehmer et al., 1994).
Approximately 90% of the wild-type ICP8 bound to the
protein A–UL9 fusion protein (Fig. 6, lane 6), as compared
with 10% of the ICP8–GFP fusion protein (Fig. 6, lane 3),
as measured by densitometry. Neither the wild-type ICP8
nor the ICP8–GFP protein was retained by the mutant D27
protein A–UL9 fusion protein (data not shown). This indi-
cated that the ICP8–GFP fusion protein was defective for
binding to UL9, possibly because the binding site(s) may be
occluded by the GFP moiety.
Characterization of intranuclear structures containing
ICP8–GFP
We first compared the distribution of ICP8 and ICP8–
GFP in Vero cells and ICP8-complementing V529 cells
Table 2
Comparison of replication compartments in Vero and V827 cells
Number of replication
compartmentsa
% of cells with indicated number
of replication compartmentsb
V827 Vero
1 or 2 42 17
3 or 4 33 22
5 3.5 37
Diffuse 9.0 9.0
Punctate 12 15
a The numbers of replication compartments were determined at 7.5 h
postinfection with the recombinant ICP8–GFP virus. Cells contained a
range of compartments with 1 or 2 large compartments to 5 or more small
compartments.
b Fifty-seven V827 cells were counted; 54 Vero cells were counted.
Fig. 5. Viral DNA synthesis at 16 h postinfection. Vero cells were mock-
infected (M), or infected with either wild-type KOS1.1 (WT) or the
recombinant ICP8-GFP virus (8GFP) in the presence or absence of PAA.
Total DNA was isolated, vacuum-blotted to a filter in five-fold dilutions,
and probed with an HSV-1-specific 32P-labeled probe.
Fig. 6. Binding of ICP8 or ICP8–GFP to a protein A-UL9 fusion protein
preabsorbed to IgG Sepharose. Protein extracts obtained from transfected
293 cells were mixed batchwise with a protein A-UL9 fusion protein
immobilized to IgG Sepharose. After the unbound fraction (FT) was
collected, the IgG Sepharose was washed with 100 mM NaCl low-salt
buffer (LS) and then 1 M NaCl high-salt buffer (HS). A portion of each
fraction (1/10 volume) was separated by SDS–PAGE, blotted to mem-
brane, and probed with the 3-83 polyclonal anti-ICP8 antibody.
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using standard immunofluorescence techniques. ICP8 and
ICP8–GFP were found in similar globular structures in
Vero cells (Figs. 7A and C, respectively) and in V529 cells
(Figs. 7B and E, respectively), suggesting that the structures
formed by ICP8–GFP in Vero and V529 cells were repli-
cation compartments.
Wild-type ICP8 reacts with the 39S conformation-spe-
cific monoclonal antibody only when it is localized to pre-
replicative sites or replication compartments (S.L. Upri-
chard, D.M. Knipe, submitted for publication). As the
addition of GFP may have altered the conformation of ICP8,
we used immunofluorescence to determine if the ICP8–GFP
fusion protein contained within replication compartments
was detected with the 39S monoclonal antibody. We in-
fected Vero cells with recombinant ICP8–GFP virus, and at
5.5 h postinfection we processed the cells for immunofluo-
rescence. ICP8–GFP was detected by the 39S monoclonal
antibody (Fig. 8B), suggesting that the addition of GFP did
not significantly alter the conformation of ICP8 and that the
ICP8–GFP fusion protein adopted a conformation similar to
that of wild-type ICP8 within replication compartments.
To further demonstrate that the ICP8–GFP-containing
structures in the nucleus were similar to wild-type replica-
tion compartments and not nonspecific aggregates of the
ICP8–GFP fusion protein, we determined if other viral
replication compartment proteins were present in infected
Vero cells within the ICP8–GFP-containing structures via
indirect immunofluorescence. Both the major viral transac-
tivator ICP4 (Fig. 8D) and the polymerase processivity
factor UL42 (Fig. 8G), previously shown to localize to
replication compartments (de Bruyn Kops et al., 1998;
Knipe et al., 1987; Liptak et al., 1996; Randall and Din-
woodie, 1986), co-localized with the ICP8–GFP fusion pro-
tein in replication compartments within the nucleus (Figs.
8F and I, respectively). Therefore, the ICP8–GFP-contain-
ing structures were similar in protein composition to wild-
type replication compartments and not simply aggregates of
the ICP8–GFP fusion protein; thus, ICP8–GFP localized to
normal replication structures in infected cells. These condi-
tions provided a system to study ICP8 localization in living
cells.
ICP8-GFP distribution in fixed cells
We next observed replication compartment formation in
Vero cells and the ICP8-complementing cell line V827 at 4
and 6.5 h postinfection with the recombinant ICP8–GFP
virus. At 4 h postinfection, the majority of ICP8–GFP was
distributed diffusely within the nucleus, but several small
structures similar to prereplicative sites were observed (Fig.
9A). These small sites were composed of only one or two
foci that contained the ICP8–GFP fusion protein (Fig. 9G).
In the V827-complementing cells, the infection in many of
the cells had progressed beyond the individual foci or dou-
blets and these cells contained what appeared to be small
compartments each consisting of several ICP8–GFP foci
(Fig. 9B).
At 6.5 h postinfection, larger compartments were ob-
served in both the Vero and the complementing V827 cells
(Figs. 9C and D, respectively). The smaller compartment
size observed in the Vero cells compared with the V827
cells may be due in part to the lower level of ICP8–GFP
viral DNA synthesis in Vero cells or the lower levels of
ICP8–GFP fusion protein compared with wild-type ICP8
protein. In both cell types, when PAA was added, the
expected punctate prereplicative sites were observed (Figs.
9E and F). Because the replication compartments were
larger in the ICP8-complementing cell line, we used these
cells in all future experiments for visualizing replication
compartment formation.
Time-lapse microscopy of replication compartment
formation
To follow the maturation of replication compartments in
cultured cells, we infected V827 cells with the ICP8–GFP
recombinant virus and acquired images at various intervals
of time. Intranuclear movement was observed on two scales.
On a small scale, the individual foci containing ICP8–GFP
that made up the replication compartments were not static,
but appeared to rotate in place or move relatively short
distances (less than the diameter of the foci) within a time
frame of seconds (not shown). In addition, on a larger scale,
small replication compartments moved through the nucleus
to merge or fuse with neighboring structures. This move-
ment took place over a time frame of minutes and greater
intranuclear distances (over 1 m). At 4.5 h postinfection,
the majority of ICP8–GFP was distributed diffusely in the
nucleus, with only a few punctate prereplicative sites (Fig.
10A) or small replication compartments (Fig. 10B) ob-
served. The three arrows in Fig. 10A at 4 h 12 min postin-
fection indicate three structures that coalesced to form the
larger compartment indicated with the arrow by 5 h 30 min
postinfection. In other cells, small replication compartments
increased in size until merging with neighboring structures
(Fig. 10B). Large replication compartments merged with
neighboring structures to eventually occupy the entire nu-
cleus (Fig. 11). The movie versions of the data may be seen
on our web site at http://knipelab.med.harvard.edu.
Discussion
ICP8-GFP fusion protein
In this study, we describe the construction and use of a
recombinant HSV-1 strain that expresses an ICP8–GFP
fusion protein to examine the dynamic intranuclear move-
ment of ICP8 into prereplicative sites and replication com-
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Fig. 7. Comparison of ICP8 and ICP8–GFP distribution patterns. Vero or V529 cells were infected with either wt or the ICP8–GFP recombinant virus. At
5.5 h postinfection, the cells were processed for immunofluorescence. The 39S MAb was used to detect both ICP8 and ICP8–GFP with a rhodamine-
conjugated secondary antibody. The ICP8–GFP fusion protein was also detected by GFP fluorescence. (A) Distribution of ICP8 in a Vero cell; (B) distribution
of ICP8 in a V529 cell; (C) distribution of ICP8–GFP in a Vero cell as detected by the 39S MAb; (D) GFP fluorescence of (C), (E) distribution of ICP8–GFP
in a V529 cell as detected by the 39S MAb, (F) GFP fluorescence of (E).
Fig. 8. Reactivity of the ICP8–GFP fusion protein with the 39S conformation-specific monoclonal antibody and co-localization with other viral replication
proteins. Vero cells were infected with the ICP8–GFP virus and processed for immunofluorescence as described under Material and Methods. (A) ICP8–GFP
detected by the 39S MAb; (B) ICP8–GFP detected by GFP fluorescence; (C) merge; (D) ICP4 detected by the 58S MAb; (E) ICP8–GFP detected by GFP
fluorescence; (F) merge; (G) UL42 detected by the 5H11D6 MAb; (H) ICP8–GFP detected by GFP fluorescence; (I) merge.
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partments. The addition of GFP to the carboxy terminus of
ICP8 resulted in a fusion protein that was partially func-
tional; however, the defect could be complemented by the
presence of wild-type ICP8 supplied in trans by infection
with wild-type HSV or by an ICP8-expressing cell line. It is
possible that the GFP portion blocks or restricts a region of
ICP8 that is required for the interaction with viral or cellular
proteins or that lower levels of ICP8–GFP made during
infection may contribute to the observed growth defect. If
this is the case, then the decreased level of ICP8–GFP may
not be sufficient to perform all the required activities of
ICP8 during infection. The presence of wild-type ICP8 in
complementing cells may stimulate viral DNA synthesis or
act in concert with the ICP8–GFP fusion protein to recruit
viral or cellular proteins required for replication or it may
simply increase the overall amount of ICP8 expressed dur-
ing the infection. The growth defect in Vero cells could be
accounted for in part by a 30-fold decrease in viral DNA
synthesis, which was probably due in part to the greater than
10-fold decrease in the ability of the ICP8–GFP fusion
protein to bind the UL9 origin-binding protein. UL9 is re-
quired for origin-dependent viral DNA synthesis (Chall-
berg, 1986), and it has been shown previously that the
ICP8–UL9 interaction is required for efficient origin-depen-
dent DNA synthesis (Boehmer et al., 1994). In an insect
cell-based, HSV-1 origin-dependent DNA replication assay,
the UL9 mutant UL9DM27, which no longer interacts with
ICP8 but retains origin binding and helicase activities, dis-
played only 5% of the levels of origin-dependent DNA
synthesis compared with wild-type UL9 controls (Boehmer
et al., 1994). This level of DNA synthesis is comparable to
the amount that we observed after infection of Vero cells
with the ICP8–GFP virus, indicating that the decreased
binding of UL9 by ICP8–GFP may account for the lower
levels of DNA replication observed in Vero cells. It is
possible that the GFP portion blocks or restricts a region of
ICP8 that is required for the interaction with UL9. In ICP8-
complementing cells infected with the recombinant ICP8–
GFP virus, the wild-type ICP8 may interact with UL9, thus
initiating viral DNA synthesis. This does not imply that the
only interaction disrupted by the addition of GFP is with
UL9; moreover, the GFP moiety may block interactions in a
larger replication complex that includes ICP8 or other in-
teractions that have not yet been described. Despite the
lowered level of viral DNA replication detected in infected
Vero cells, prereplicative sites and replication compart-
ments were observed, suggesting that the decreased level of
DNA synthesis was sufficient to promote replication com-
partment formation. This suggests that the ICP8–UL9 inter-
action may not be directly required for ICP8 intranuclear
targeting and for the formation of replication compartments.
However, it is possible that the weaker binding of ICP8–
GFP to UL9 may be sufficient for intranuclear localization
to prereplicative sites. Previous studies have shown that in
transfected Vero cells, co-expression of the three subunits of
the helicase–primase complex with wild-type ICP8 was
sufficient to localize ICP8 to prereplicative sites (Liptak et
al., 1996), suggesting, that in certain circumstances, UL9 is
not absolutely required for the intranuclear localization of
ICP8.
The intranuclear structures containing the ICP8–GFP
fusion protein had properties similar to those previously
reported for wild-type ICP8-containing replication compart-
ments. For example, the ICP8–GFP fusion protein co-lo-
calized with the ICP4 and UL42 proteins, both of which
Fig. 9. Distribution of the ICP8–GFP fusion protein at various times
postinfection in fixed cells. Vero cells (A, C, E) or V827 cells (B, D, F, G)
were infected with the recombinant ICP8–GFP virus and processed at the
indicated times postinfection. (A) Vero cell at 4 h postinfection (1000
mag.); (B) V827 cell at 4 h postinfection (1000 mag.); (C) Vero cells at
6.5 h postinfection (630 mag.); (D) V827 cells at 6.5 h postinfection
(630 mag.); (E) same as (C) in the presence of PAA; (F) same as (D) in
the presence of PAA. (G) Closeup of ICP8–GFP containing doublets at 4 h
postinfection.
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localize to replication compartments. The ICP8–GFP pro-
tein intranuclear distribution was also similar to that ob-
served for wild-type ICP8, which consisted of punctate foci
within the boundaries of the replication compartment. These
data supported the use of the ICP8–GFP protein as a model
for intranuclear targeting of ICP8.
Fig. 10. Small replication compartments merge to form larger compartments. Time-lapse analysis of replication compartment formation in cultured cells.
V827 cells were infected with the ICP8–GFP virus. At 4 h postinfection, images were acquired at 3-min intervals. The composite images shown were
generated using selected images from the indicated times postinfection (hour:minute). (A) The three arrows at 4:12 point to three structures that merged to
form the larger compartment indicated with an arrow at 5:30. (B) The three arrows at 4:30 show three replication compartments that enlarged to form the
compartment indicated with the arrow at 4:54.
Fig. 11. Replication compartments fuse with neighboring structures to fill the nucleus. Time-lapse analsysis of replication compartment formation in cultured
cells. V827 cells were infected with the ICP8–GFP virus. At 5.5 h postinfection, images were acquired at 3-min intervals. The composite image shown was
generated using selected images from the indicated times postinfection (hour:minute).
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Intranuclear movement of viral replication structures
We show here that the HSV prereplicative sites and
replication compartments initiate at a few distinct structures
and then at least some traverse through the intranuclear
environment to fuse with one another. Early during infec-
tion, the ICP8–GFP fusion protein localized to several
small structures within the nucleus. It is unknown if the
ICP8–GFP fusion protein is targeting to a preexisting cel-
lular structure that is adjacent to ND10 or if viral proteins
accumulate at a new intranuclear structure required for viral
DNA replication or gene expression. It has recently been
reported that cellular sites of DNA synthesis initiate at a few
sites within the nucleus (Kennedy et al., 2000). It is possible
that viral proteins, including ICP8–GFP, localize to a sub-
population of cellular replication sites that form adjacent to
ND10. Further studies are required to determine if ICP8 or
other viral proteins co-localize with mammalian origin-
associated proteins, such as those in the ORC or MCM
families. If this is true, then, it is possible that the virus is
usurping preformed cellular DNA replication complexes to
aid in its own DNA replication.
The coalescence of smaller, distant sites or the merging
of neighboring replication compartments formed larger
compartments that eventually filled the nucleus. We ob-
served movement on two scales. The first was a rapid,
small-scale local movement of individual ICP8–GFP foci
within replication compartments that occurred over short
distances. The second type involved movement over greater
intranuclear distances but on a slower time frame on the
order of minutes. To summarize, once prereplicative sites or
small compartments formed, large replication compart-
ments formed by two mechanisms: (1) distant, small struc-
tures moved to coalesce into larger compartments (Fig.
12A), and (2) the compartments grew by accretion while
maintaining the same relative position within the nucleus
and larger compartments formed when the boundaries of
adjacent compartments merged (Fig. 12B).
Multiple mechanisms may be responsible for replication
compartment movement and coalescence. To address this,
we must first consider the types of intranuclear movements
observed normally in cells. Many studies suggest that chro-
matin movement is restrained during interphase in the mam-
malian nucleus, with movements restricted to 0.3–0.5
m, which is the result of Brownian motion or diffusion
(Abney, 1997; Manders et al., 1999; Marshall et al., 1997;
Shelby et al., 1996; Zink et al., 1998). These mechanisms
may account for the rapid, small-scale movements of the
ICP8–GFP foci, but possibly not for the large-scale move-
ments of replication compartments. Despite the evidence of
a relatively immobile mammalian cell nucleus, at least one
report has shown evidence for cell cycle-regulated intranu-
clear chromatin movement (Tumbar and Belmont, 2001).
This was demonstrated when a region of transcriptionally
silent chromatin located normally at the nuclear periphery
was permanently redistributed to the nuclear interior on
insertion of a transcriptionally active locus (Tumbar and
Belmont, 2001). This large-scale movement took place on a
time scale of minutes, but only during G1 or S phase. More
evidence exists for cell cycle- and developmentally regu-
lated intranuclear movement in other organisms such as
Drosophila (Gunawardena and Rykowski, 2000; Vazquez
et al., 2001) or budding yeast (Heun et al., 2001), but these
organisms may have a functionally different nuclear archi-
tecture compared with mammalian cells due to increased
heterochromatin amounts in mammalian cells, which may
limit intranuclear movements. The mechanisms required for
these examples of intranuclear movements are unknown,
and it remains to be determined whether active or passive
forces are responsible.
It is intriguing to suggest that an active mechanism is
responsible for the movements of prereplicative sites and
replication compartments. It is possible that the virus may
assemble an intranuclear molecular motor that can propel
compartments through the interchromosomal spaces. Mo-
tors consisting of actin and myosin are well documented in
the cytoplasm, but their presence or action in the nucleus
has not been conclusively demonstrated. Recently, it was
proposed that actin filaments play a role in the activity of a
transcriptional complex (Zhao, 1998), suggesting that an
actin-dependent activity is required in the nucleus. Others
have demonstrated that nuclear myosin 1 interacted and
co-localized with RNA polymerase II (Nowak et al., 1997;
Pestic-Dragovich et al., 2000), again suggesting that molec-
ular motors exist and have a functional role in the nucleus.
Future work is required to determine if molecular motor
proteins, such as actin and myosin, are required for viral
replication compartment coalescence. However replication
Fig. 12. Models for maturation of replication compartments. The two
models of compartment maturation are shown. The nucleus is represented
by the large oval. (A) Intranuclear movement and coalescence of smaller
compartments with neighboring structures. (B) Growth of replication com-
partments by accretion and the resulting fusion of adjacent structures.
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compartment coalescence is directed, it is clear that this has
a profound effect on the preexisting nuclear architecture. It
has been shown recently that herpesviruses may have
evolved mechanisms for disrupting the nuclear lamina (Mu-
ranyi et al., 2002; Scott and O’Hare, 2001). The disruption
of nuclear laminins, which are an integral part of the nuclear
framework, may lead to a higher nuclear plasticity, thus
allowing for the movement of viral replication structures. In
HSV-infected cells, other compartments within the nucleus
may be altered and the chromatin is marginalized to the
nuclear periphery (Darlington and James, 1966; Monier et
al., 2000; Schwartz and Roizman, 1969; Sirtori and Bosisio-
Besteti, 1967). Channels of nucleoplasm that normally run
throughout the interchromosomal space to the nuclear pores
may be blocked or disrupted by the growth of replication
compartments, thus possibly inhibiting or slowing normal
cellular functions such as mRNA trafficking out to the
cytoplasm. This may be another general mechanism for how
HSV alters cellular functions to promote its own replicative
success.
Materials and methods
Cells and viruses
African green monkey kidney (Vero) and human 293
cells were grown and maintained in Dulbecco’s modified
Eagle’s medium (Mediatech, Inc.) with 5% fetal bovine
serum  5% fetal calf serum, glutamine, streptomycin, and
penicillin (DMEM  10% FCS). The ICP8-complementing
cell lines S2 (Gao and Knipe, 1989), V827 (Da Costa et al.,
2000), and V529 (Da Costa et al., 2000), which express
ICP8, ICP8 and ICP27, and ICP8 and UL5, respectively,
were grown and maintained in DMEM 10% FCS G418
(400 g/ml).
The herpes simplex 1 KOS 1.1 wild-type strain, origi-
nally obtained from M. Levine, was propagated and assayed
on Vero cells. The HD-2 mutant virus (Gao and Knipe,
1989) is a replication-defective HSV-1 strain that expresses
the first 250 amino acid residues of ICP8 fused to -galac-
tosidase. The ICP8–GFP recombinant virus and the HD-2
mutant ICP8 virus were propagated on either S2 or V827 cells.
Plasmids
To construct pICP8–GFP, sequences encoding ICP8 and
green fluorescent protein (GFP) were first cloned into the
pCI (Promega)-derived vector pCIAflII (Murphy et al.,
2000) as follows. A 732-bp NotI fragment containing the
GFP open reading frame (ORF) from pGreenLantern
(Gibco-BRL) was cloned into the NotI site of pCIAflII to
generate pCIA–GFP. A 3.8-kb EcoRI/AvrII fragment con-
taining the entire ICP8 ORF from pSV8.2 (Gao and Knipe,
1993) was cloned into the EcoRI and XbaI sites of pCIA–
GFP. The fusion protein ORF was generated by mutating
the ICP8 stop codon via polymerase chain reaction (PCR)-
mediated site-directed mutagenesis with Pfu DNA polymer-
ase (Stratagene) (1 cycle 95°C 2 min; 12 cycles 95°C 30 s,
55°C 1 min, 68°C 18 min). The two primers used for
changing the stop codon to an arginine residue were 5-
CAACCCCTCTCAGCATATCCAACG-3 (antisense) and
5-CGTTGGATATGCTGAGAGGGGTTG-3 (sense) (Life
Technologies). The altered nucleotide is in boldface. After
PCR amplification, the reaction was digested with DpnI,
and 1 l of the reaction was used to transform bacteria. The
resulting vector was designated pCMV–8GFP.
The pCMV-8.3 plasmid was generated by removing the
3.8-kb EcoRI/AvrII fragment containing the ICP8 sequence
from the pSV8.3 plasmid (Gao and Knipe, 1991) and sub-
cloning it into the EcoRI and XbaI sites of pCIAfIII.
Isolation of a recombinant HSV-1 expressing the
ICP8–GFP fusion protein
The sequence encoding the C-terminal ICP8–GFP fusion
protein from pCMV–8GFP was cloned into a vector con-
taining UL29 flanking sequences as follows. The EcoRI site
172 nucleotides upstream from the ICP8 start codon and the
HpaI site 147 nucleotides downstream of the GFP stop
codon in pCMV–8GFP were filled in and converted to BglII
restriction sites by the insertion of a 12-bp BglII oligonu-
cleotide linker (5-GGAAGATCTTCC-3) (New England
Biolabs). The resulting 4.7-kb BglII fragment was cloned
into the BglII site of pICP8PA (M. Chen, D.M. Knipe,
unpublished results), a plasmid that contains the ICP8 pro-
moter, poly(A), and additional downstream sequence, to
make the plasmid p8-8GFP. To generate the ICP8–GFP
recombinant virus via homologous recombination, linear-
ized p8-8GFP and HD-2 viral DNA (Gao and Knipe, 1989)
were co-transfected via the calcium phosphate method into
the V827-complementing cell line. HD-2 is a replication-
defective virus that expresses a truncated ICP8 fused to the
-gal. Linear p8-8GFP was transfected with various molar
ratios of HD-2 viral DNA to plasmid DNA (1:10, 1:15,
1:20) and brought to a total of 16 g DNA with salmon
sperm DNA. An equal volume of 2 HEPES-buffered
saline, pH 7.05 (270 mM NaCl, 10 mM KCl, 1.4 mM
Na2HPO4, 2% dextrose, 42 mM HEPES) was added to the
DNA. The volume was brought up to 600 l with 1
Hepes-buffered saline, and then 40 l of 2.0 M CaCl2 was
added dropwise. The tubes were mixed gently and incubated
at room temperature for 15 min. The suspension was then
added to flasks of subconfluent V827 cells and incubated at
room temperature for 30 min, after which 5 ml of DMEM
10% FBS was added, and the flasks were placed at 37°C. On
the following day, the cells were washed twice and overlain
with fresh medium. Four days later, the cells were harvested
by adding 2.5 ml sterile milk and freeze–thawing twice. The
lysate was sonicated three times on ice for 30 s on/ 30 s off.
The lysate was then serially diluted and plated on V827
cells. An inverted, fluorescent Nikon microscope equipped
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with a FITC filter set was used to screen for fluorescent
plaques.
Complementation assay
Vero cells in six-well plates were transfected in duplicate
using the Lipofectamine reagent (Gibco-BRL) with 1 g of
pCMV-8.3 or pCMV–8GFP and 3 g carrier DNA, or 4 g
carrier DNA as a negative control. At 24 h posttransfection,
the cells were infected at a m.o.i. of 5 with HD-2. At one
hour postinfection, the cells were washed (40 mM sodium
citrate, 135 mM NaCl, 10 mM KCl, pH 3.0) twice for 30 s
to inactivate excess extracellular virus. The cells were har-
vested 24 h later by freeze–thawing twice and sonicating
three times on ice for 30 s. The yield was determined by
titration on the S2-complementing cell line.
Viral yield assay
Vero or V529 cells in T25 flasks were infected at a m.o.i.
of 3 with either wild-type KOS 1.1 or the recombinant
ICP8–GFP virus. One hour after infection the cells were
washed (40 mM sodium citrate, 135 mM NaCl, 10 mM KCl,
pH 3.0) to inactivate extracellular virus. At 2, 12, or 24 h
postinfection, the cells were harvested by freeze–thawing
and sonicating three times for 30 s on ice. The yield was
determined by titration on V529 cells.
Viral DNA synthesis assays
Vero cell monolayers were infected with either KOS1.1
or the ICP8–GFP virus at a m.o.i. of 10 in the presence or
absence of a specific viral DNA inhibitor, phosphonoacetic
acid (PAA), at a concentration of 400 g/ml. At 16 h
postinfection, total DNA was obtained by disrupting the
cells in 3 ml of lysis buffer (10 mM Tris–Cl, pH 8.0, 10 mM
EDTA, pH 8.0, 2% SDS, 100 g/ml proteinase K) and
incubating overnight at 37°C. After the addition of 0.3 ml of
3 M sodium acetate (pH 5.2), lysates were extracted once
with phenol:chloroform and then once with chloroform.
After precipitation with 2 vol of 70% ethanol and resuspen-
sion in 700 of l TE buffer (10 mM Tris–HCl, pH 8.0, 1
mM EDTA), the lysate was incubated with RNase A (25
g/ml) for 30 min at 37°C. Seventy microliters of 3 M
sodium acetate (pH 5.2) was added, and the samples were
once again extracted with phenol:chloroform and then once
with chloroform. The DNA was precipitated on ice for 1 h
by the addition of an equal volume of 1.6 M NaCl–13%
PEG. The DNA was then resuspended in TE buffer and
quantitated. Equivalent amounts of DNA were applied to a
nitrocellulose filter in fivefold dilutions (2000–16 ng in
12 SSC) via a dot-blotter apparatus. The filter was then
probed with the HSV-1-specific 32P-labeled plasmid
pSV8.3. Exposure and quantification of the filter were with
a Bio-Rad GS-525 Molecular Imager and Multi-Analyst
software.
Preparation of protein extracts
Protein extracts were obtained from two 150-cm2 culture
flasks of 293 cells transfected with either pSV8.3 or pCMV–
8GFP DNA with the SuperFect reagent (Qiagen) as per the
manufacturer’s instructions. At 48 h posttransfection, the
cells were washed twice with phosphate-buffered saline,
pelleted, and resuspended in 2 ml of high-salt buffer (1.2 M
NaCl, 20 mM HEPES–NaOH, pH 7.5, 10% (v/v) glycerol,
1 mM DTT, 1 mM EDTA, one Complete-Mini protease
inhibitor cocktail tablet (Roche) per 7 ml buffer). The ly-
sates were sonicated on ice three times for 30 s and then
clarified by centrifugation at 4°C in an Eppendorf mi-
crofuge. The lysates were dialyzed overnight against low-
salt buffer (100 mM NaCl, 20 mM HEPES–NaOH, pH 7.5,
10% (v/v) glycerol, 1 mM DTT, 0.1 mM EDTA), and then
cleared by centrifugation at 4°C for 30 min in an Eppendorf
microfuge. After the addition of 1 M MgCl2 to 20 mM and
200 units of DNase I, the lysates were incubated at 4°C for
2 h and then stored at 80°C.
UL9 binding assay
Five hundred-milliliter cultures of DH5 Escherichia coli
containing either the pB1 or pD27 plasmid were grown in
Luria broth overnight at 37°C. The pelleted cells were
washed three times with 100 ml TE (10 mM Tris–HCl, pH
7.6, 1 mM EDTA). After resuspension in 10 ml of lysis
buffer (50 mM Tris–HCl, pH 7.6, 150 mM NaCl, 0.05%
Tween 20, 1 mM EDTA, one Complete-Mini protease in-
hibitor cocktail tablet per 10 ml buffer), lysozyme was
added to 200 g/ml, and the cells were incubated at room
temperature for 20 min. The cells were sonicated on ice, and
the lysates were clarified by centrifugation at 4°C in a
Sorvall centrifuge at 15,000 rpm for 1 h. The lysates were
incubated overnight at 4°C after the addition of 1 M MgCl2
to 20 mM and 400 units of DNase I. The lysates were
aliquoted and stored at 80°C.
One milliliter of B1 or D27 lysate was added to 0.5 ml of
IgG Sepharose Fast Flow 6, equilibrated as per the manu-
facturer’s directions (Pharmacia Biotech), batchwise in mi-
crofuge tubes. The slurry was incubated at 4°C for 30 min
with gentle agitation. The IgG Sepharose slurry was washed
three times with TST buffer (50 mM Tris–Cl, pH 7.6, 150
mM NaCl, 0.05% Tween 20), and then twice with low-salt
buffer (100 mM NaCl, 20 mM HEPES–NaOH, pH 7.5, 10%
(v/v) glycerol, 1 mM DTT, 0.1 mM EDTA). After 0.5 ml of
either wild-type ICP8 or ICP8–GFP extract was added to
the protein A–UL9/IgG Sepharose preparations, the slurry
was incubated for 1 h at 4°C with gentle agitation. The
slurry was centrifuged at 4°C in an Eppendorf microfuge for
1 min. The supernatant was removed and kept as the flow-
through fraction. The slurry was subsequently washed twice
with 0.5 ml of low-salt buffer and then 0.5 ml of high-salt
elution buffer (1 M NaCl, 20 mM HEPES–NaOH, pH 7.5,
10% (v/v) glycerol, 1 mM DTT, 0.1 mM EDTA). The two
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0.5-ml wash fractions were combined for a final volume of
1 ml. A portion of each fraction (1/10 vol) was separated by
SDS–PAGE, transferred to a PVDF membrane (Bio-Rad),
and probed with the ICP8 3-83 polyclonal antibody. Input
and recovery of protein was monitored by loading decreas-
ing twofold dilutions of total lysate equivalent to 1/10th,
1/20th, and 1/40th of the lysate on a gel that was prepared
in parallel. The amount bound was determined as the per-
centage of total protein in the high-salt fraction as measured
by densitometry of the film.
Visualization of ICP8-GFP
Vero or V529 cells were grown on 22  22-mm cover-
slips in six-well trays. For short-term live cell analysis, the
coverslip was removed at the indicated time postinfection,
washed briefly in PBS, and then placed onto a glass slide for
observation. For fixed cell analysis, the coverslip was
washed in PBS, fixed for 5 min in 3.7% formaldehyde in
PBS, washed twice in PBS and once in distilled water, and
then mounted onto glass slides with gelatin.
Cells were viewed with an Axioplan 2 (Zeiss) micro-
scope equipped with an Orca cooled CCD camera
(Hamamatsu Photonics). A Zeiss 40 or 63 plan Apo-
chromat objective was used. Images were collected with the
OpenLab software package (Improvision). Figures were
prepared with Canvas 5.0 (Deneba).
Indirect immunofluorescence
For indirect immunofluorescence of cultured cells, Vero
cells were plated on 18-mm coverslips in a 24-well tray. At
5.5 h postinfection with the ICP8–GFP virus, the cells were
washed briefly in PBS and then fixed for 5 min in 3.7%
formaldehyde in PBS. After being washed with PBS for 5
min, the cells were subsequently permeabilized with cold
acetone for 2 min. The cells were then rinsed in distilled
water and washed for 5 min in PBS. Primary antibody was
then applied at a 1:50 dilution of one of the following: the
58S anti-ICP4 monoclonal antibody, the 39S anti-ICP8
monoclonal antibody, or the 5H11D6 anti-UL42 monoclo-
nal antibody. After being washed three times for 5 min in
PBS, a 1:100 dilution of a rhodamine-conjugated goat anti-
mouse antibody was used as a secondary antibody for de-
tection. After a final wash in PBS, the coverslips were
mounted onto glass slides with gelatin. The same micro-
scope setup used for observing ICP8–GFP was used for
indirect immunofluorescence.
Analysis of viral proteins
Vero cells in 25-cm2 culture flasks were mock-infected
or infected at a m.o.i. of 10 with wild-type KOS 1.1, the
recombinant ICP8–GFP virus, or the replication-defective
virus HD-2. At the indicated times postinfection, the cells
were incubated for 30 min at 37°C in labeling medium
(Eagle’s minimum essential medium, without methionine or
cysteine (Sigma), supplemented with 1% dialyzed fetal bo-
vine serum and 100 Ci/ml EXPRE35S35S labeling mix
(NEN)). The cells were harvested by the addition of 1 ml of
SDS sample buffer (100 mM Tris–HCl, pH 6.8, 4% SDS,
20% glycerol, 200 mM DTT, 0.2% bromphenol blue). The
proteins were separated on a 9.25% gel by SDS–PAGE. The
gel was dried and exposed to BioMax MR film (Kodak).
For immunodetection of the ICP8 protein by Western
blot, the 3–83 polyclonal antibody was used at a dilution of
1:1000 in TBST (20 mM Tris–HCl, pH 7.5, 150 mM NaCl,
1% Tween 20). The membrane was blocked with TBST plus
5% milk for 30 min at room temperature before the addition
of 3–83 antiserum. The membrane was washed three times
for 15 min with TBST at room temperature after primary
and secondary antibody incubations. An HRP-conjugated
goat anti-rabbit secondary antibody (Santa Cruz Biotech-
nology) was used at a dilution of 1:5000 in TBST. Enhanced
chemiluminescence reagents were used as directed by the
manufacturer (Amersham Pharmacia Biotech).
Time-lapse video microscopy
S2 cells for time-lapse analysis were grown on 18-mm
glass coverslips in six-well plates. A DeltaVision micro-
scope system (Applied Precision Instruments) assembled
around an Axiovert microscope (Zeiss) and a PXL CCD
camera (Photometrics Ltd.) was used to view the cells. A
Zeiss 63X plan Apochromat objective was used. The tem-
perature was held constant at 37°C with an objective
warmer (Bioptechs, Inc.). Cells were maintained in CO2
independent medium (Gibco-BRL) plus 1% heat-inacti-
vated fetal bovine serum for the duration of the time-lapse
procedure.
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